BCAB — Bioatla Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $2.10 Analyst target: $10.00 Upside: 376.19%

See the full interactive analysis & chart →

Informational only — not investment advice.